Takeda says coronavirus treatment trial using recovered patients' blood could start in July

Takeda Pharmaceutical Co Ltd could start a clinical trial as early as July for a potential treatment of COVID-19 that is based on antibodies from recovered patients' blood, company executives said on Wednesday.